Anika Therapeutics | ANIK - 销售成本

股票价格
14.76
每天变化
-0.46 -3.02%
每月一次
2.79%
每年
8.21%
Q2 预测
14.36




销售成本 更改 日
Abbott USD 4.92B 535M 2025-12
Agenus USD 642K 399K 2025-09
Agios Pharmaceuticals USD 1.88M 199K 2025-12
Anika Therapeutics USD 11.44M 797K 2025-12
Halozyme Therapeutics USD 102.15M 29.14M 2025-12
Heron Therapeutics USD 11.12M 795K 2025-12
Insmed USD 46.16M 15.25M 2025-12
Integra LifeSciences USD 193.44M 1.62M 2025-12
Intrexon USD 1.01M 344K 2024-06
J&J USD 7.97B 689M 2025-12
Karyopharm Therapeutics USD 1.48M 35.95M 2025-12
Ligand Pharmaceuticals USD 11.9M 733K 2025-09
MacroGenics USD 10.12M 34.18M 2025-12
Merit Medical Systems USD 198.58M 838K 2025-12
Rigel Pharmaceuticals USD 8.03M 5.22M 2024-09
Sangamo BioSciences 2.42M 1.11M 2024-06
Sanofi EUR 4.29B 421M 2025-12
Smith & Nephew USD 870M 17M 2025-12
Stryker USD 2.69B 373M 2025-12
Surmodics USD 9.49M 23.54M 2025-06
Veracyte USD 39.28M 1.93M 2025-12
Xencor USD 61.66M 50.95M 2025-06
Zimmer Biomet Holdings USD 970.1M 234.3M 2025-12